Mannatech (MTEX) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Mannatech (MTEX) has outperformed Regencell Bioscience (RGC) over the past year, losing 6.4% versus a loss of 60.7%. Over five years, RGC leads with a +1455.6% price change compared with -77.8% for MTEX.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MTEX | RGC |
|---|---|---|
| Share price | $7.86 | $7.63 |
| Market cap | $15.17M | — |
| 1-day change | +1.81% | +7.31% |
| YTD return | -4.73% | -63.67% |
| 1-year return | -6.43% | -60.67% |
| 5-year return | -77.80% | +1455.56% |
| EPS (TTM) | $-3.91 | $-0.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $12.45 | $69.00 |
| 52-week low | $3.80 | $4.51 |
| Distance from 52-week high | -36.87% | -88.94% |
| Average volume | 25.90K | 199.19K |
| Shares outstanding | 1.93M | — |
| Employees | 170 | 10 |
| Sector | Consumer Defensive | Health Care |
| Industry | Food Distribution | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MTEX has outperformed RGC by 54.2 percentage points over the past year.
- The two companies sit in different sectors: Mannatech in Consumer Defensive and Regencell Bioscience in Health Care.
About Mannatech
MTEX stock →Mannatech, Incorporated operates as a wellness solution provider. The company develops markets and sells nutritional supplements; skin care and anti-aging products; and weight-management and fitness products.
Consumer Defensive · Food Distribution · 170 employees
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
MTEX vs RGC FAQ
Which stock has performed better over the past year, MTEX or RGC?
MTEX returned -6.43% over the past 12 months, compared with -60.67% for RGC (price return, excluding dividends). Past performance does not predict future results.
Are Mannatech and Regencell Bioscience in the same industry?
No. Mannatech is in the Consumer Defensive sector, while Regencell Bioscience is in Health Care.